Please specify your interest and sign up for our newsletter

* indicates required

Newsletter Archive

Read all NCOH newsletters on the Newsletter Archive page

Professor Marion Koopmans - Honorary Doctor Technical University of Denmark

On Friday April 28, Prof. Marion Koopmans received the degree of Honorary Doctor from the Technical University of Denmark.

Professor Marion Koopmans was honoured with the degree of Honorary Doctor. She is head of the Department of Viroscience at Erasmus MC and a well-known and respected virologist with a large interest in international collaboration.

During the Ebola epidemic, she was responsible for the execution of the mobile labs in Sierra Leone and Liberia, and she closely collaborates with the National Food Institute from Denmark.

Read more: Professor Marion Koopmans – Honorary Doctor Technical University of Denmark – Erasmus MC

More News

57 ideas for prevention or reduction of antibiotic resistence

In the second round of the programme Antibiotic Resistence 57 project ideas were submitted. These projects will contribute to the prevention of reduction of antibiotic resistence, with the ‘OneHealth’ approach and behavioural changes as possible perspectives for research.

More

"Towards a global one health" booklet

On 9 March 2017, Wageningen University & Research celebrated its 99th Dies Natalis with the theme 'Towards a global one health'.

More

The NACTAR call is out

NACTAR stands for Novel Antibacterial Compounds and Therapies Antagonizing Resistance. This research programme on the development of new antibiotics and alternatives is commissioned by the Dutch Ministry of Health, Welfare and Sport and NWO-domain TTW and connects to the National Antibiotic Development Platform (NADP).

More

Netherlands Antibiotic Development Platform launched

On 18 April 2017, the Netherlands Antibiotic Development Platform (NADP) was launched in Utrecht with the project partner, and representatives from science, industry, and government. The aim of the launch event was to show how NADP can help facilitate the next step from academic discovery to accelerate R&D to develop new antibiotics and alternatives to antibiotics.

More
Want to see more news?